Edwards Lifesciences Other intangible assets—net increased by 8.8% to $1.23B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.5%, from $1.17B to $1.23B. Over 5 years (FY 2020 to FY 2025), Other intangible assets—net shows an upward trend with a 27.8% CAGR.
An increase typically follows acquisitions, while a steady decrease reflects ongoing amortization of existing intangible assets.
This represents the net book value of identifiable non-physical assets such as acquired technology, patents, customer li...
Standard for companies that grow through M&A, often labeled 'Intangible assets, net'.
non_current_assets_intangible_assets_net_excluding_goodwill| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $327.00M | $325.30M | $323.60M | $322.00M | $320.70M | $266.50M | $285.20M | $446.80M | $431.40M | $429.80M | $428.40M | $446.80M | $417.10M | $956.10M | $1.18B | $1.17B | $1.17B | $1.13B | $1.13B | $1.23B |
| QoQ Change | — | -0.5% | -0.5% | -0.5% | -0.4% | -16.9% | +7.0% | +56.7% | -3.4% | -0.4% | -0.3% | +4.3% | -6.6% | +129.2% | +23.1% | -0.1% | -0.2% | -3.6% | -0.2% | +8.8% |
| YoY Change | — | — | — | — | -1.9% | -18.1% | -11.9% | +38.8% | +34.5% | +61.3% | +50.2% | +0.0% | -3.3% | +122.5% | +174.6% | +163.0% | +181.2% | +18.3% | -4.1% | +4.5% |